Altogether, these data indicate that short‐term treatment with LSD1i induces a durable shift in cell fate in MCC, driven by the disassembly of the LSD1‐CoREST complex and a sustained activation of master regulators of the neuronal lineage. The gene discussed is RCOR1; the disease is Merkel cell skin cancer.